首页> 外国专利> NEUROTRANSMITTER-BASED BRAIN MAPPING METHOD AND USE OF BRAIN MAP

NEUROTRANSMITTER-BASED BRAIN MAPPING METHOD AND USE OF BRAIN MAP

机译:基于神经递质的大脑映射方法和脑地图的使用

摘要

An embodiment pertains to a method for evaluating efficacy of a drug which increases or decreases the secretion of a particular neurotransmitter, by measuring a concentration change of the particular neurotransmitter in a specific intracerebral site with reference to a brain map, the method comprising the steps of: selecting as a microdialysis target region in the brain map a first site of an animal, which corresponds to a site that the brain map represents as being the highest in the concentration of a first neurotransmitter of which the secretion is increased or decreased by the drug; and injecting the drug to the animal and monitoring a concentration change of the first neurotransmitter in the first site between pre- and post-injection of the drug. The brain map is constructed by acquiring a concentration distribution of 11 or more multiple neurotransmitters including serotonin, dopamine, GABA, glutamate, and metabolites thereof, obtained by mass analysis of samples acquired from multiple sites in the human brain -hereinafter referred to as first concentration distribution- and a concentration distribution of 11 or more multiple neurotransmitters including serotonin, dopamine, GABA, glutamate, and metabolites thereof, obtained by mass analysis of samples acquired from multiple sites in a monkey brain -hereinafter referred to as second concentration distribution-, and utilizing first correlation including at least 11 correlation data resulting from matching the multiple sites of the human brain to the multiple sites of the monkey brain on the basis of similarity in the concentration distribution of the individual neurotransmitters between the first concentration distribution acquired and the second concentration distribution acquired, and the second concentration distribution, wherein the first site corresponds to a second site in the second concentration distribution when the first neurotransmitter is the most abundant at the second site in the first concentration distribution.
机译:一个实施方案涉及用于评估药物的功效的方法,其通过参考脑地图测量特定脑内位点中的特定神经递质中的特定神经递质的浓度变化,该方法包括以下方法:选择作为脑图中的微透析目标区域,其动物的第一位点,其对应于脑图代表分泌的第一神经递质的浓度最高的部位,其中药物增加或减少药物;并将药物注入动物并监测第一个位点在药物预注射和注射后的第一位点的浓度变化。通过获取11个或更多个多种神经递质剂的浓度分布构建脑图,包括血清素,多巴胺,GABA,谷氨酸和代谢物,通过对来自人脑中的多个位点中获得的样品的质量分析 - Rente inte浓度通过从猴脑中获得的多个位点中获取的样品 - Reply分布的多个位点的样品的质量分析,将11或更多的多种神经递质的分布和浓度分布在包括血清素,多巴胺,GABA,谷氨酸及其代谢物。利用包括至少11个相关数据的第一相关性,从而基于所获得的第一浓度分布的单个神经递质的浓度分布的相似性与猴脑的多个位点匹配到猴脑的多个位点。分发acqui.红色和第二浓度分布,其中第一位点对应于当第一神经递质在第一浓度分布中的第二位点最丰富的第二浓度分布中的第二位点。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号